CRVS
Corvus Pharmaceuticals Inc.
Latest News for CRVS
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Keros Therapeutics (KROS), Jasper Therapeutics (JSPR) and Corvus ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Apogee Therapeutics (APGE), Intellia Therapeutics (N......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Apogee Therapeutics (APGE), Intellia Therapeutics (N......
Barclays analyst Etzer Darout maintained a Buy rating on Corvus Pharmaceuticals today and set a price target of $28.00. Darout covers the Healthcar......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRVS | $12.50 | -3.3% | 1.67M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corvus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW